Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex

60Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A divalent cation-dependent association between heparin or heparan sulfate and the ectodomain of the fibro-blast growth factor (FGF) receptor kinase (FGFR) restricts FGF-independent transphosphorylation between self- associated FGFR and determines specificity for and mediates binding of activating FGF. Here we show that only the fraction of commercial heparin or rat liver heparan surfate which binds to immobilized antithrombin formed an FGF-binding binary complex with the ectodomain of the FGFR kinase. Conversely, only the fraction of heparin that binds to immobilized FGFR inhibited Factor Xa in the presence of antithrombin. Only the antithrombin- bound fraction of heparin competed with 3H-heparin bound to FGFR in absence of FGF, whereas both antithrombin-bound and unretained fractions competed with radiolabeled heparin bound independently to FGF-1 and FGF-2. The antithrombin-bound fraction of heparin was required to support the heparin- dependent stimulation of DNA synthesis of endothelial cells by FGF-1. The requirement for divalent cations and the antithrombin-binding motif distinguish the role of heparan sulfate as an integral subunit of the FGFR complex from the wider range of effects of heparan sulfates and homologues on FGF signaling through FGFR-independent interactions with FGF.

Cite

CITATION STYLE

APA

McKeehan, W. L., Wu, X., & Kan, M. (1999). Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. Journal of Biological Chemistry, 274(31), 21511–21514. https://doi.org/10.1074/jbc.274.31.21511

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free